featured
Efficacy of Nirmatrelvir–Ritonavir in Reducing the Severity of Postacute Sequelae of SARS-CoV-2 Infection in Adults
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Internal Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Nirmatrelvir-Ritonavir and Symptoms in Adults With Postacute Sequelae of SARS-CoV-2 Infection: The STOP-PASC Randomized Clinical Trial
JAMA Intern Med 2024 Jun 07;[EPub Ahead of Print], LN Geng, H Bonilla, H Hedlin, KB Jacobson, L Tian, P Jagannathan, PC Yang, AK Subramanian, JW Liang, S Shen, Y Deng, BJ Shaw, B Botzheim, M Desai, D Pathak, Y Jazayeri, D Thai, A O'Donnell, S Mohaptra, Z Leang, GZM Reynolds, EF Brooks, AS Bhatt, RW Shafer, MG Miglis, T Quach, A Tiwari, A Banerjee, RN Lopez, M De Jesus, LR Charnas, PJ Utz, U SinghFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.